Tolnafate Aerosol, Spray
NDC 68016-653
Product Information
Tolnafate (tolnaftate jock itch powder spray - talc free) is a OTC MONOGRAPH DRUG-approved product labeled by Chain Drug Consortium, Llc. Tolnaftate is used to treat skin infections such as athlete's foot, jock itch, and ringworm. It is supplied as a aerosol, spray for topical administration. This product entry covers the primary NDC 68016-653 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 68016-653?
What are the uses of this product?
What are Active Ingredients of this product?
- TOLNAFTATE 1.3 g/130g - A synthetic antifungal agent.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- TOLNAFTATE (UNII: 06KB629TKV)
- TOLNAFTATE (UNII: 06KB629TKV) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
- ISOBUTANE (UNII: BXR49TP611)
- KAOLIN (UNII: 24H4NWX5CO)
- PPG-12-BUTETH-16 (UNII: 58CG7042J1)
- ALCOHOL (UNII: 3K9958V90M)
- ZEA MAYS SUBSP. MAYS WHOLE (UNII: 1G5HNE09V8)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 705934 - tolnaftate 1 % Powder Spray
- RxCUI: 705934 - tolnaftate 0.01 MG/MG Powder Spray
* Please review the full disclaimer at the bottom of this page.
Patient Education
Tolnaftate
Tolnaftate stops the growth of fungi that cause skin infections, including athlete's foot, jock itch, and ringworm. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
[Learn More]
* Please review the full disclaimer at the bottom of this page.